Form Type: 4

SEC EDGAR Link
Accession Number:0000315066-22-001673
Date:2022-07-12
Issuer: VERVE THERAPEUTICS, INC. (VERV)
Original Submission Date:

Reporting Person:

FMR LLC
245 SUMMER STREET
BOSTON, MA 02210

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2022-07-12 S 100,000 d $19.98 633,729 indirect
COMMON STOCK 2022-07-12 S 63,000 d $22.04 570,729 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 as the result of a scrivener's error, the form 4 for verve therapeutics inc. submitted on july 6, 2022, to the commission for trades that occurred on july 1, 2022, misreported the amount of securities beneficially owned following the reported transactions as 773,729 common shares of verve therapeutics. the amount of securities beneficially owned by f-prime capital partners healthcare fund v lp as of july 1, 2022 was 733,729 common shares following the disposal of 38,775 common shares.
WhaleWisdom Logo

Elevate your investments